Gene: METTL1
Official Full Name: methyltransferase 1, tRNA methylguanosineprovided by HGNC
Gene Summary: This gene is similar in sequence to the S. cerevisiae YDL201w gene. The gene product contains a conserved S-adenosylmethionine-binding motif and is inactivated by phosphorylation. Alternative splice variants encoding different protein isoforms have been described for this gene. A pseudogene has been identified on chromosome X. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00375 | METTL1 Knockout cell line(293T) | Human | METTL1 | 1:3~1:6 | Negative | Online Inquiry |
METTL1 Gene Knockout Cell Lines represent a state-of-the-art tool utilized in molecular biology to study the role of the METTL1 gene, which is implicated in RNA methylation processes. These knockout cell lines are generated using CRISPR-Cas9 technology, effectively disabling the METTL1 gene and thereby enabling researchers to observe the resultant phenotypic and molecular changes associated with its loss. This can provide critical insights into the regulatory functions of methylation in gene expression, RNA stability, and overall cellular homeostasis.
The key function of the METTL1 Gene Knockout Cell Lines lies in their ability to facilitate the exploration of methylation's involvement in various biochemical pathways. By comparing knockout cells to wild-type controls, researchers can elucidate the consequences of METTL1 depletion on RNA metabolism, identify downstream targets, and assess pathogenic mechanisms related to diseases, including cancer and neurological disorders. This capacity to dissect complex biological interactions underscores their scientific importance, positioning these cell lines as invaluable tools in both basic and applied research settings.
In terms of advantages, the METTL1 Gene Knockout Cell Lines offer unprecedented specificity and efficiency, as traditional methods such as RNA interference often lead to off-target effects, whereas CRISPR technology provides a precise modification without unwanted mutations. Moreover, the availability of multiple lines with various genetic backgrounds enhances their usability across a range of experimental conditions, making them adaptable for diverse research purposes.
For researchers and clinicians, the value of employing METTL1 Gene Knockout Cell Lines cannot be overstated. They not only advance the understanding of gene function and regulation but can also serve as a foundation for developing new therapeutic strategies targeting methylation-related pathways. Ultimately, utilizing these cell lines can significantly accelerate scientific discovery and innovation.
Our company prides itself on delivering high-quality biological products backed by rigorous scientific validation and expertise. We are committed to supporting the research community by providing cutting-edge tools that drive forward the frontiers of biological understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.